Cipla InvaGen signed an exclusive deal with Qilu Pharmaceutical to license QL2107, a Keytruda biosimilar, in the US. For those wondering what a biosimilar actually...
Tata Electronics and Merck signed a Memorandum of Understanding (MoU) on 2nd September to strengthen Indiaβs semiconductor capabilities. The partnership focuses on semiconductor materials, fabrication...
According to filings with the US Securities and Exchange Commission, contract management software-as-a-service (SaaS) unicorn Icertis has raised $75 million in debt financing. The debt...
On Wednesday, shares of Moderna (NASDAQ:MRNA) are up about 14% in pre-market trading after Merck (NYSE:MRK) exercised its option to develop and commercialise a personalised...